Flowchart Symbol Codes in Clinical Trials

Clinical trials generate enormous amounts of data about how participants move through a study who gets screened, who's enrolled, who drops out, and who completes treatment. Without a clear visual system to track all of that, research teams risk miscommunication, protocol errors, and audit failures. Flowchart symbol codes in clinical trials solve this problem by giving everyone involved from principal investigators to regulatory reviewers a shared visual language for documenting study processes precisely and consistently.

What Are Flowchart Symbol Codes in Clinical Trials?

Flowchart symbol codes are standardized shapes and notations used to map out the design, conduct, and reporting of a clinical trial. Each shape carries a specific meaning. A rectangle typically represents a process or intervention step. A diamond signals a decision point. An oval marks the start or end of a pathway. When these symbols follow consistent coding rules, the resulting flowchart communicates complex trial logic at a glance.

In clinical research, these symbol codes appear in study protocols, statistical analysis plans, CONSORT flow diagrams, and regulatory submissions. They help document participant flow from screening through randomization, treatment, follow-up, and analysis. If you've ever seen the standard participant flow diagram in a published clinical trial report, you've already encountered these codes in action.

For those who want to build a stronger foundation in how different shapes function across contexts, our guide on interpreting flowchart symbol codes at an advanced level covers the nuances that matter when diagrams get complex.

Why Do Researchers Need Standardized Flowchart Symbols for Study Design?

Clinical trials involve multiple teams biostatisticians, clinical operations, data management, monitors, and ethics committees. Everyone needs to understand the study flow without ambiguity. Standardized symbol codes eliminate guesswork.

When a protocol uses inconsistent or invented symbols, reviewers waste time asking what each shape means. Worse, site staff may misinterpret eligibility criteria or visit schedules. Regulatory bodies like the FDA expect clear, traceable documentation. A well-structured flowchart with proper symbol coding reduces the chance of protocol deviations and speeds up review cycles.

The CONSORT (Consolidated Standards of Reporting Trials) statement, widely adopted in medical publishing, specifically recommends flowcharts that use standardized symbols to show participant movement through each phase of a trial. Journals increasingly require these diagrams before accepting trial results for publication. You can read more about CONSORT's reporting requirements at consort-statement.org.

Which Flowchart Symbols Are Most Common in Clinical Trial Diagrams?

While general-purpose flowcharts use dozens of symbol types, clinical trial diagrams rely on a smaller, focused set:

Rectangle (Process box): Represents an action or step screening, randomization, drug administration, lab test, follow-up visit
Rectangle with rounded corners (Predefined process): Often used for standard procedures like adverse event assessment or consent
Diamond (Decision): Shows a branching point does the participant meet eligibility criteria? Yes or no.
Oval/Terminal (Start/End): Marks where the trial flow begins or ends "Screening begins" or "Study completion"
Parallelogram (Input/Output): Indicates data collection or results blood sample drawn, lab result received
Arrow (Flow line): Connects symbols and shows the direction of movement through the study
Dashed arrow or line: Typically indicates an alternative or optional pathway

For a broader overview of how these symbols apply beyond clinical settings, our resource on flowchart symbol codes for visual communication explains how the same shapes work across industries.

How Does the CONSORT Flow Diagram Use These Symbols?

The CONSORT flow diagram is the most recognized application of flowchart symbols in clinical trials. It tracks participants through four stages: enrollment, allocation, follow-up, and analysis. Here's how the standard symbols map to each stage:

Enrollment

A rectangle at the top typically shows the total number of participants assessed for eligibility. Decision diamonds branch into those who met inclusion criteria and those who did not, with boxes documenting reasons for exclusion.

Allocation

Participants are split into groups using process rectangles. For randomized controlled trials, you'll see branching paths for each arm intervention group, control group with numbers in each box showing how many were assigned.

Follow-Up

Rectangles track how many participants in each arm received the intended treatment, were lost to follow-up, or discontinued. Arrows connect each stage clearly.

Analysis

At the bottom, terminal-style boxes show how many participants were included in the primary analysis and whether any were excluded and why.

Every number in a CONSORT flowchart must match data in the trial report. This is one reason symbol consistency matters a missing box or unclear branch raises questions about data integrity.

What's the Difference Between Standard and Custom Symbol Codes?

Some research organizations develop internal symbol coding conventions that go beyond standard ISO 5807 or ANSI shapes. For example, a sponsor might color-code rectangles to distinguish between safety-related procedures and efficacy assessments. Others add numbering systems inside each symbol for cross-referencing with the protocol document.

Customization can be useful when a trial has unusual complexity adaptive designs, multiple interim analyses, or platform trials testing several interventions simultaneously. But custom symbols need to be defined in a legend on the flowchart itself. Without that legend, the diagram loses its communication value, especially for external reviewers or auditors who aren't familiar with the organization's internal standards.

What Are the Most Common Mistakes With Flowchart Symbols in Trial Documentation?

Errors in clinical trial flowcharts aren't just cosmetic they can delay approvals, confuse site staff, or undermine the credibility of published results. Here are the most frequent problems:

Using a rectangle where a diamond is needed: If a step involves a yes/no decision (like eligibility screening), it should be a diamond, not a rectangle. Mixing these up hides branching logic.
Omitting the legend: Even when using standard symbols, a legend is essential especially in regulatory submissions where different reviewers may have varying familiarity with flowchart conventions.
Inconsistent participant counts: Numbers in each box should add up correctly throughout the flow. A common error is showing 200 enrolled but only accounting for 195 through the rest of the diagram without explaining the discrepancy.
Overcrowded diagrams: Trying to fit every sub-process into one flowchart creates a confusing mess. Use high-level flowcharts for the main study path and link to detailed sub-diagrams for specific procedures.
Missing drop-out reasons: In CONSORT diagrams, each excluded or withdrawn participant needs a documented reason. Leaving these blank or vague invites reviewer pushback.

How Can You Create Accurate Flowcharts for Your Own Clinical Trial?

Start by mapping the study protocol section by section. Identify every decision point, treatment step, data collection event, and endpoint. Then assign the correct symbol to each element before you start drawing.

A practical approach:

List all major study milestones screening, consent, baseline assessment, randomization, treatment periods, follow-up visits, close-out
Identify branching logic eligibility yes/no, treatment arm assignment, early termination triggers
Assign symbols using standard conventions (rectangles for processes, diamonds for decisions, ovals for start/end)
Add participant numbers once data is available these are required for CONSORT compliance
Review with cross-functional teams have the biostatistician, medical monitor, and project manager each verify their section
Include a legend and version date on every flowchart submitted externally

Tools like Microsoft Visio, Lucidchart, draw.io, or even the drawing features in Microsoft Word can produce clean clinical trial flowcharts. The tool matters less than the accuracy and consistency of the symbol coding within it.

What Should You Check Before Submitting a Trial Flowchart?

Before any flowchart goes into a protocol, regulatory submission, or journal manuscript, run through this checklist:

☐ Every decision point uses a diamond shape with clear yes/no or category branches
☐ All process steps use rectangles with concise, unambiguous descriptions
☐ The diagram has a clear start (oval) and end point
☐ Participant numbers add up correctly at every stage
☐ Drop-out and exclusion reasons are explicitly stated
☐ A legend defines every symbol and color used
☐ The flowchart matches the protocol text exactly no steps are added or missing
☐ Version number and date are displayed on the diagram
☐ The diagram follows CONSORT guidelines if it's for a published RCT
☐ At least one person outside the core team has reviewed it for clarity

Getting these details right from the start saves time during regulatory review and protects the credibility of your trial data. If your team regularly produces these diagrams, consider creating a standard template with pre-coded symbols that everyone follows. Consistency across studies within a program builds trust with reviewers and reduces rework on every new submission.